Opportunity ID: 309235
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | EP-IDS-18-004 |
Funding Opportunity Title: | QUICKFIRE |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.360 — Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 24, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Sep 25, 2018 No Explanation |
Current Closing Date for Applications: | Sep 25, 2018 No Explanation |
Archive Date: | Oct 25, 2018 |
Estimated Total Program Funding: | $100,000 |
Award Ceiling: | $100,000 |
Award Floor: | $100,000 |
Eligibility
Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Assistant Secretary for Preparedness and Response |
Description: | Janssen Research & Development, LLC and BARDA will collaborate on a global challenge for reimagined, transformative respiratory protection. Traditional respiratory protective devices used to protect against inhalation of harmful infectious agents were designed for use in occupational settings, to guard against inhalation of dangerous particulates. Disposable versions, such as N95 respirators, are only available for adults, must be fit-tested to ensure proper functioning, and can be uncomfortable to wear. In an outbreak of a novel or newly emerging respiratory disease, respiratory protection may be the only countermeasure available to protect health care workers and the general public.
Janssen Research & Development, LLC will partner with JLABS, which exists to foster innovation in health care products and executes QuickFire Challenges for health care innovation. There is no direct equivalent of the QuickFire Challenge services for innovation specific to health care as is provided by JLABS. Its unique service will directly benefit BARDA’s mission to make available medical countermeasures to address health security threats. Supporting innovation is an authority provided to BARDA under the Public Health Service Act and partnering with a company providing a diverse array of products and leveraging its expertise and infrastructure has the potential to provide solutions to the challenges in developing new respiratory devices. Reimagined, innovative respiratory protection would contribute directly to ASPR’s mission to save lives and protect Americans against 21st Century health security threats. Respiratory protection is often the first line of defense, and a radically improved approach to protect both health care workers and the general public, including children, would truly improve our ability to respond to public health emergencies. By generating interest and focusing innovation efforts on reimagining respiratory protection, BARDA’s goal for the QuickFire Challenge is for the resulting innovative approaches to be eligible for continued testing and development and eventual regulatory approval, so that these revolutionary products can be widely available and used. |
Link to Additional Information: | QUICKFIRE |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Contact the grantsolutions helpdesk and register for access via Phone Number: 1.866.577.0771 or 202.401.5282
Email: help@grantsolutions.gov help@grantsolutions.gov Email:help@grantsolutions.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|